Modelling the Effect of Short-Course Multidrug-Resistant Tuberculosis Treatment in Karakalpakstan, Uzbekistan
du Cros, P
MetadataShow full item record
AbstractMultidrug-resistant tuberculosis (MDR-TB) is a major threat to global TB control. MDR-TB treatment regimens typically have a high pill burden, last 20 months or more and often lead to unsatisfactory outcomes. A 9-11 month regimen with seven antibiotics has shown high success rates among selected MDR-TB patients in different settings and is conditionally recommended by the World Health Organization.